114 related articles for article (PubMed ID: 7397632)
21. Doxorubicin and cyclophosphamide chemotherapy for disseminated endometrial cancer.
Seski JC; Edwards CL; Gershenson DM; Copeland LJ
Obstet Gynecol; 1981 Jul; 58(1):88-91. PubMed ID: 7195533
[TBL] [Abstract][Full Text] [Related]
22. Adriamycin, 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU, NSC 409962) and cyclophosphamide therapy of drug-resistant metastatic breast carcinoma.
Presant CA; Van Amburg A; Klahr C
Cancer; 1977 Sep; 40(3):987-93. PubMed ID: 902247
[TBL] [Abstract][Full Text] [Related]
23. A randomized comparison of cyclophosphamide, Adriamycin, and 5-fluorouracil with triethylenethiophosphoramide and methotrexate, both as sequential and as fixed rotational treatment in patients with advanced ovarian cancer.
Bruckner HW; Dinse GE; Davis TE; Falkson G; Creech RH; Arseneau JC; Greenspan EM; Brodovsky HS; Pagano M; Hahn RG
Cancer; 1985 Jan; 55(1):26-40. PubMed ID: 3917352
[TBL] [Abstract][Full Text] [Related]
24. Phase II trial of doxorubicin/docetaxel/cyclophosphamide for locally advanced and metastatic breast cancer: results from NSABP trial BP-58.
Smith RE; Anderson SJ; Brown A; Scholnik AP; Desai AM; Kardinal CG; Lembersky BC; Mamounas EP
Clin Breast Cancer; 2002 Dec; 3(5):333-40. PubMed ID: 12533263
[TBL] [Abstract][Full Text] [Related]
25. Long-term results of a cisplatin-containing combination chemotherapy regimen for the treatment of advanced ovarian carcinoma.
Louie KG; Ozols RF; Myers CE; Ostchega Y; Jenkins J; Howser D; Young RC
J Clin Oncol; 1986 Nov; 4(11):1579-85. PubMed ID: 3095501
[TBL] [Abstract][Full Text] [Related]
26. Advanced ovarian cancer: long-term results of treatment with intensive cisplatin-based chemotherapy of brief duration.
Hainsworth JD; Grosh WW; Burnett LS; Jones HW; Wolff SN; Greco FA
Ann Intern Med; 1988 Feb; 108(2):165-70. PubMed ID: 3124679
[TBL] [Abstract][Full Text] [Related]
27. A randomized comparison of doxorubicin alone versus doxorubicin plus cyclophosphamide in the management of advanced or recurrent endometrial carcinoma: A Gynecologic Oncology Group study.
Thigpen JT; Blessing JA; DiSaia PJ; Yordan E; Carson LF; Evers C
J Clin Oncol; 1994 Jul; 12(7):1408-14. PubMed ID: 8021731
[TBL] [Abstract][Full Text] [Related]
28. Intravenous Corynebacterium parvum: an adjunct to chemotherapy for resistant advanced ovarian cancer.
Rao B; Wanebo HJ; Ochoa M; Lewis JL; Oettgen HF
Cancer; 1977 Feb; 39(2):514-26. PubMed ID: 837334
[TBL] [Abstract][Full Text] [Related]
29. The CHAD and HAD regimens in advanced ovarian cancer: combination chemotherapy including cyclophosphamide, hexamethylmelamine, adriamycin, and cis-dichlorodiammineplatinum(II).
Vogl SE; Berenzweig M; Kaplan BH; Moukhtar M; Bulkin W
Cancer Treat Rep; 1979 Feb; 63(2):311-7. PubMed ID: 109202
[TBL] [Abstract][Full Text] [Related]
30. Chemotherapy in advanced ovarian carcinoma: current standards of care based on randomized trials.
Thigpen T; Vance R; Puneky L; Khansur T
Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S97-107. PubMed ID: 7835816
[TBL] [Abstract][Full Text] [Related]
31. Combination chemotherapy in advanced ovarian carcinoma.
Amadori D; Ravaioli A; Maltoni M; Ridolfi R; Gentilini P; Giunchi DC; Frassineti L; Falcini F; Amadori M
Tumori; 1986 Oct; 72(5):519-24. PubMed ID: 3798574
[TBL] [Abstract][Full Text] [Related]
32. [Cisplatin, adriamycin and cyclophosphamide combination chemotherapy of epithelial ovarian cancer].
Sawada M; Ozaki M; Inagaki M; Hongo J; Hirota Y; Takayama K; Arimoto Y; Wada T; Taki I; Yanagita T
Gan To Kagaku Ryoho; 1987 Dec; 14(12):3301-4. PubMed ID: 3120644
[TBL] [Abstract][Full Text] [Related]
33. Adriamycin-cyclophosphamide and adriamycin-cis-dichloro-diammineplatinum(II) combination chemotherapy in patients with advanced cancer.
Higby DJ; Wilbur D; Wallace HJ; Henderson ES; Weiss R
Cancer Treat Rep; 1977 Aug; 61(5):869-73. PubMed ID: 329980
[TBL] [Abstract][Full Text] [Related]
34. Six-drug chemotherapy (hexamethylmelamine, doxorubicin, cisplatin, cyclophosphamide, methotrexate, and 5-FU; CHAMP-5) for ovarian carcinoma: alternating sequences of combination regimens.
Pasmantier MW; Coleman M; Silver RT; Ballard WP
Cancer Treat Rep; 1985 Jun; 69(6):689-93. PubMed ID: 3926310
[TBL] [Abstract][Full Text] [Related]
35. Adriamycin plus alkylating agents in the treatment of metastatic breast cancer.
Lokich JJ; Skarin AT; Mayer RJ; Henderson IC; Blum RH; Frei E
Cancer; 1977 Dec; 40(6):2801-5. PubMed ID: 338136
[TBL] [Abstract][Full Text] [Related]
36. Platinum, anthracycline, and alkylating agent-based chemotherapy for ovarian carcinosarcoma.
Signorelli M; Chiappa V; Minig L; Fruscio R; Perego P; Caspani G; Battistello M; Colombo N
Int J Gynecol Cancer; 2009 Aug; 19(6):1142-6. PubMed ID: 19820383
[TBL] [Abstract][Full Text] [Related]
37. Combination chemotherapy of advanced endometrial adenocarcinoma with adriamycin, cyclophosphamide, 5-fluorouracil, and medroxyprogesterone acetate.
Bruckner HW; Deppe G
Obstet Gynecol; 1977 Jul; 50(1 Suppl):10s-12s. PubMed ID: 876531
[TBL] [Abstract][Full Text] [Related]
38. cis-Dichlorodiammineplatinum(II) alone followed by adriamycin plus cyclophosphamide at progression versus cis-dichlorodiammineplatinum(II), adriamycin, and cyclophosphamide in combination for adenocarcinoma of the lung.
Britell JC; Eagan RT; Ingle JN; Creagen ET; Rubin J; Frytak S
Cancer Treat Rep; 1978 Aug; 62(8):1207-10. PubMed ID: 688256
[TBL] [Abstract][Full Text] [Related]
39. Intensive surgical and chemotherapeutic management of advanced ovarian cancer.
Griffiths CT; Fuller AF
Surg Clin North Am; 1978 Feb; 58(1):131-42. PubMed ID: 417410
[TBL] [Abstract][Full Text] [Related]
40. Combination chemotherapy for advanced breast cancer utilizing vincristine, adriamycin, and cyclophosphamide (VAC).
Rainey JM; Jones SE; Salmon SE
Cancer; 1979 Jan; 43(1):66-71. PubMed ID: 761176
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
